Revenue +13.7% and NPAT +36.5% on post-COVID royalty recovery

Group operating revenue (excluding IFRS 16 lease income and government wage subsidies) rose 13.7% to $10.7m, which management attributes to higher royalty income on rebuilding system sales versus FY22 lockdown periods. Total revenue from continuing operations grew 8.4% to $11.3m on the company's disclosure.

EBITDA margin held at 15.3%, modestly above the four-period historical mean of 15.0% and inside the 12.6%–17.5% range. Management reports NPAT of $552,316, up 36.5% from $404,525 in HY22, with profit before tax lifting from $527,555 to $746,635.

The balance sheet finished with $7.4m of cash, $58k of borrowings (i.e. effectively unlevered), $40.1m of total assets and $11.5m of equity.

Per the release, the gain reflects higher system sales as franchise activity normalised after COVID lockdowns (management estimates system sales were down ~$5.9m in FY22 due to lockdowns). This matters because franchise royalty income carries through to EBITDA at high incremental margin, and the margin held at 15.3% rather than slipping — consistent with operating recovery rather than promotional buying of sales.

Earnings quality at the operating level looks clean. OCF/EBITDA cash conversion of 76.5% is above the four-period mean of 68.2% and within the historical range, and capex intensity of 4.5% of revenue is consistent with an asset-light franchise model. Pre-lease free cash flow of $0.8m covered roughly 1.4x reported NPAT, supporting the earnings figure rather than diverging from it.

The balance sheet is unusually liquid for the operating base. $7.4m of net cash against an annualised revenue run-rate near $21m leaves substantial optionality, but it also caps the return profile — ROE of 4.8% is at the lower edge of the four-period range (4.7%–9.5%) until that cash is deployed.

The FY22 seasonality shape is not a useful template either: HY22 carried 95.9% of FY22 NPAT and 374.4% of FY22 operating cash flow, because the second half of FY22 was hit by lockdowns. That distortion means readers cannot lean on the prior-year split to anchor a second-half estimate.

What the release does support is a recovering top-line trajectory and an EBITDA margin profile inside the historical band. What it does not support is any specific call on second-half marketing spend, new-site openings, or the path of system-wide sales as the cycling-COVID tailwind fades.

EBITDA of $1.6m converted to $1.3m of operating cash flow (76.5% conversion, above the four-period mean), capex was modest at $0.5m, and pre-lease FCF covered reported NPAT. Effective tax rate of 26.0% sits at the lower edge of the four-period range (26.0%–34.7%), so the NPAT growth is not flattered by an outsized tax-rate tailwind versus the prior period.

The one area to watch is inventory: inventory days of 12.1 sit at the upper edge of the recent range (mean 9.7), pointing to a modest stock build at company-operated sites. The absolute amounts are small for a franchise group, so the read-through is limited, but it is the only working-capital line not consistent with a clean recovery.

This briefing cannot assess full-year FY23 outcomes because the release contains no forward guidance, no second-half operating context, and the FY22 seasonality shape is distorted by lockdown disruption.